Metraipolis › archive › dc_4ef30600f671

Infant Growth After Mass Administration of Azithromycin: Secondary Outcomes of a Cluster Randomized Clinical Trial — Europe PMC PMID:42268611

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42268611
DOI
10.1001/jamanetworkopen.2026.17425
License (as archived)
solo-consultazione
Archived
2026-10-07T13:23:47.302Z
SHA-256 of the archived text
d8a43d31e2a4c9b3cf87a9c1d16db1461c3406b776fb02fb52c51870d0722330
Stable URL of this page
https://metraipolis.com/documento/dc_4ef30600f671

How to cite

Infant Growth After Mass Administration of Azithromycin: Secondary Outcomes of a Cluster Randomized Clinical Trial — Europe PMC PMID:42268611 — Europe PMC (en), https://europepmc.org/article/MED/42268611 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ef30600f671 (Metraipolis archive dc_4ef30600f671, sha256 d8a43d31e2a4c9b3cf87a9c1d16db1461c3406b776fb02fb52c51870d0722330)
BibTeX
@misc{dc4ef30600f671,
  title = {Infant Growth After Mass Administration of Azithromycin: Secondary Outcomes of a Cluster Randomized Clinical Trial — Europe PMC PMID:42268611},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42268611},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ef30600f671; sha256 d8a43d31e2a4c9b3cf87a9c1d16db1461c3406b776fb02fb52c51870d0722330},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42268611. Agents can read the archived copy with the MCP tool read_document.